Chemomab Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update

/PRNewswire/ -- Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative...

Related Keywords

Israel ,Irina Koffler ,Dale Pfost ,Donald Marvin ,David Weiner ,Jack Lawler ,Barbara Lindheim ,Wadi Mor ,Development Rd Expenses ,Strategic Communications ,Leeds University ,Lifesci Advisors ,Chemomab Therapeutics Ltd ,Nasdaq ,Chemomab Therapeutics ,New Drug ,Chemomab Clinical ,Ordinary Share ,Ordinary Shares ,Annual Report ,Private Securities Litigation Reform ,Chief Executive Officer ,Sci Advisors ,Vice President ,Public Relations ,Balance Sheets ,Td ,